Here are the 8-K filings from Born Inc (BRRN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow BRRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BRRN filings page.
Bryn Inc. (BRRN) disclosed that it filed a Certificate of Amendment to its Articles of Incorporation in Nevada to implement a Reverse Stock Split effective at 6:00 P.M. PDT on September 23, 2026. No fractional shares will be issued. Holders of fewer than 100,000 shares will receive $0.00007 in cash per pre-split share. For holders of more than 100,000 shares, any fractional share resulting from the Reverse Stock Split will be rounded up to the next whole share. The common stock is expected to begin trading on a reverse-split-adjusted basis on the OTCID Market on September 24, 2026. Bryn Inc. has applied to change its trading symbol to “MEDO,” while the symbol remains “BRRN” until any change is implemented, and the common stock has been assigned a new CUSIP number 099863201 effective following the Reverse Stock Split.
Bryn Inc. reports a change in control and new leadership. On April 24, 2026, MEDO Healthcare LLC bought 10 million shares of Bryn’s Series A-1 Preferred Stock from Custodian Ventures LLC for $175,000 in cash. Each preferred share carries the voting power of 250 common shares, so this block represents the voting power of 2.5 billion common shares.
Bryn has 450 million common shares and 10 million Series A-1 Preferred shares outstanding, giving MEDO Healthcare about 84.7% of the company’s voting power. As part of the transaction, David Lazar resigned as sole officer and director. He appointed John Leo as sole director and CEO and Arthur Magee as CFO and Secretary, bringing extensive investment banking and capital markets experience to the company’s management team.